Newsroom
Sorted by: Latest
-
CoreWeave Announces Proposed $3.0 Billion Convertible Senior Notes Offering
LIVINGSTON, N.J.--(BUSINESS WIRE)--CoreWeave, Inc. (Nasdaq: CRWV) (“CoreWeave”) today announced its intention to offer, subject to market and other conditions, $3.0 billion aggregate principal amount of its convertible senior notes due 2032 (the “Notes”) in a private offering. CoreWeave also intends to grant the initial purchasers of the Notes an option to purchase, for settlement within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an addition...
-
Samson Rock Capital LLP UK Regulatory Announcement: Form 8.3 - Amendment
LONDON--(BUSINESS WIRE)-- FORM 8.3 This form has been republished in replacement of yesterday’s disclosure to amend section 2a(Total) PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehic...
-
CamundaCon 2026 Brings the Global Orchestration Community Together to Break Through the Automation Ceiling
AMSTERDAM--(BUSINESS WIRE)--Camunda, the enterprise platform for agentic orchestration, will host its CamundaCon 2026 conference at the Beurs van Berlage in Amsterdam on May 19-21, 2026. The three-day event – themed The Agentic Orchestration Conference – will be the biggest ever CamundaCon, gathering the global community of leaders, enterprise architects, developers, and operations executives to address how to break through the automation ceiling. This is one of the defining enterprise challeng...
-
Chevron Confirms Oil Discovery at Bandit Prospect in Gulf of America
HOUSTON--(BUSINESS WIRE)--Chevron Corporation (NYSE:CVX) today confirmed an oil discovery at the Bandit prospect in the Gulf of America, as announced by operator Occidental. The exploration well is located in Green Canyon Block 680, about 125 miles south of the Louisiana coast. The well encountered high-quality, full-to-base oil-bearing Miocene sands. The co-owners are currently evaluating results to determine next steps. The discovery has the potential for subsea tie-backs to an adjacent Occid...
-
Stellantis N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – STLA
LOS ANGELES--(BUSINESS WIRE)--Stellantis N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – STLA...
-
Valmont Appoints John Schwietz as Chief Financial Officer and Reiterates Full-Year 2026 Financial Guidance
OMAHA, Neb.--(BUSINESS WIRE)--Valmont® Industries, Inc. (NYSE: VMI), a global leader that provides products and solutions to support vital infrastructure and advance agricultural productivity, today announced the appointment of John L. Schwietz as the Company’s Chief Financial Officer. Avner Applbaum, Valmont Chief Executive Officer said, “I am pleased to appoint John as Valmont’s CFO. He is a proven leader with deep experience across our business segments and a strong track record in both fina...
-
Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that Company management will present at the 25th Annual Needham Virtual Healthcare Conference on Thursday, April 16th, 2026 at 12:45 p.m. ET. The live webcast of the presentation may be accessed via the Events and Presentations section of the Sensei website at investors.senseibio.com. A replay of the webcast will be available for approximately 90 days following the event. About Sensei Biotherapeutics Sensei Bio...
-
GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is working with Eli Lilly and Company to expand access to the newly FDA-approved oral GLP-1 medication, Foundayo™ (orforglipron). Eligible self-pay patients can access Foundayo through GoodRx at a starting price of $149 per month, in line with the lowest available discounted cash price at launch. The offering provides transparent pricing and nationwide...
-
Snap-on Incorporated to Webcast 2026 First Quarter Results Conference Call
KENOSHA, Wis.--(BUSINESS WIRE)--Snap-on will release 2026 first quarter results prior to market open on April 23, 2026, with a call discussing the results to follow at 10:00 a.m. ET....
-
NEUPATH HEALTH TO PRESENT AT THE 2026 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE
TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”) operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain medical services markets, today announced that Stephen Lemieux, CEO, will present and participate in one-on-one meetings at the 2026 Bloom Burton & Co. Healthcare Investor Conference to be held...